Premium
P1‐214: Long‐term administration of active immunotherapy CAD106 in phase IIa open‐label extension studies in Alzheimer's disease patients
Author(s) -
Graf Ana,
Andreasen Niels,
Farlow Martin,
Riviere MarieEmmanuelle,
Quarg Peter,
Caputo Angelika,
Vostiar Igor,
Winblad Bengt,
Orgogozo JeanMarc
Publication year - 2012
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2012.05.493
Subject(s) - tolerability , medicine , adverse effect , antibody titer , titer , antibody , immunotherapy , surgery , gastroenterology , immunology , cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom